This dividend share yields under 1% — but I’d still buy it

This dividend share has a low yield. So why would our writer consider adding it to his income portfolio?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

pensive bearded business man sitting on chair looking out of the window

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Often when looking at dividend shares, it can be tempting to zoom in on high yields. Over time, big dividend yields can be very rewarding. I certainly own some high-yielders in my portfolio.

But sometimes, a dividend share attracts me despite a small current payout — because of what I think it might deliver in future.

Focussed business model

An example of this is Judges Scientific (LSE: JDG). If you have never heard of this company, you are not alone. It operates in a niche sector, supplying scientific instruments to customers like universities, commercial labs, and research agencies.

The company management figured out that this industry is highly fragmented. In other words, there are lots of instrument makers that are very small. Some have just a handful of employees, and when the owner retires they may simply wind up the business.

That presents an opportunity for a company like Judges. With limited competition from other bidders, it is able to buy many such small manufacturers at attractive valuations. Focussing on a single area helps to grow Judges’ expertise. So it can help the companies it acquires with things like strategic advice and access to capital. Aside from that, it tends to leave them alone to focus on what they do best.

Profit potential

So far, so good. But what makes this business model attractive from an income perspective?

When it comes to scientific instruments, accuracy and reliability are the name of the game. That means that purchasing decisions tend not to be driven by cost. Instead, customers are looking for a very high level of quality.

That gives a company like Judges pricing power. It can set prices without worrying too much about competition from low-cost producers, for example. By building a reputation for product quality in a specialist area, over time its revenues have grown but not at the cost of attractive profit margins.

Dividend share with growth potential

Last year, the firm made post-tax profits of £13m on revenue of £91m. That sort of profit margin attracts me. As it continues to grow through its acquisitive strategy, I reckon Judges can hopefully keep growing earnings.

At the moment, the dividend yield is only 0.9%. That is low and not especially attractive to me. But what I do like is Judges’ aggressive approach to growing the dividend. Last year saw dividend growth of 20%. The year before was a more modest but still impressive 10%, while before that the payout had increased by 25% for two years in a row.

Past performance is not necessarily indicative of what will come next. But I think Judges’ history of double-digit percentage dividend increases reflects the lucrative nature of its business model. Admittedly, that may not continue. Ongoing pandemic restrictions in some markets may lead to sales being postponed or cancelled. Other companies could copy Judges’ business model, pushing up the purchase price for acquisitions and hurting profit margins.

But so far, Judges has impressed me with its strategy and ability to deliver strong dividend growth. I would consider buying this dividend share for my portfolio not because of its current yield, but the potential for ongoing growth in the payout.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Christopher Ruane has no position in any of the shares mentioned. The Motley Fool UK has recommended Judges Scientific. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Black man sat in front of laptop while wearing headphones
Investing Articles

Down 53% in a year! I reckon this oversold FTSE 100 stock is now ripe for a comeback

This FTSE 100 stock has fallen out of fashion with investors, but Harvey Jones reckons the sell-off has gone too…

Read more »

Young Asian man drinking coffee at home and looking at his phone
Investing Articles

How much second income would I get if I put £10k into dirt cheap Centrica shares?

Centric shares have been looking incredibly cheap despite rocketing in recent years. Harvey Jones wonders whether this is an opportunity…

Read more »

artificial intelligence investing algorithms
Investing Articles

If I’d invested £10k in AstraZeneca shares three months ago here’s what I’d have now

Harvey Jones is kicking himself for failing to buy AstraZeneca shares before the took off. Is there still a decent…

Read more »

A senior group of friends enjoying rowing on the River Derwent
Investing Articles

How I’d find shares to buy for an early retirement

Christopher Ruane explains some of the factors he considers when looking for shares to buy that could potentially help him…

Read more »

Investing Articles

Why I’d snap up bargain UK shares to try and build wealth

Christopher Ruane explains how he hopes to find high-quality UK shares selling at attractive prices, to help him build wealth…

Read more »

Young Caucasian woman at the street withdrawing money at the ATM
Investing Articles

Here’s how I’d target a £2k annual second income from a £20k Stocks & Shares ISA

Our writer explains how he’d try to earn thousands of pounds annually in dividends by investing a £20k ISA in…

Read more »

Mother and Daughter Blowing Bubbles
Investing Articles

5 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Investing Articles

The £20k Stocks and Shares ISA might be one of the better things about living in the UK

The £20k Stocks and Shares ISA doesn't have many equivalents in other countries. Here's why these accounts can help UK…

Read more »